| Basics |
|
Terns Pharmaceuticals, Inc.
|
| IPO Date: |
February 1, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$2.64B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.33 | 4.13%
|
| Avg Daily Range (30 D): |
$0.85 | 4.51%
|
| Avg Daily Range (90 D): |
$0.45 | 3.78%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.65M |
| Avg Daily Volume (30 D): |
4.17M |
| Avg Daily Volume (90 D): |
2.07M |
| Trade Size |
| Avg Trade Size (Sh.): |
105 |
| Avg Trade Size (Sh.) (30 D): |
95 |
| Avg Trade Size (Sh.) (90 D): |
94 |
| Institutional Trades |
| Total Inst.Trades: |
760 |
| Avg Inst. Trade: |
$1.8M |
| Avg Inst. Trade (30 D): |
$1.87M |
| Avg Inst. Trade (90 D): |
$1.78M |
| Avg Inst. Trade Volume: |
.2M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.91M |
| Avg Closing Trade (30 D): |
$4.37M |
| Avg Closing Trade (90 D): |
$2.4M |
| Avg Closing Volume: |
201.82K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-1.02
|
$-.27
|
$-.26
|
|
Diluted EPS
|
$-1.02
|
$-.27
|
$-.26
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -94.44M
|
$ -24.64M
|
$ -24.09M
|
|
Operating Income / Loss
|
$ -108.48M
|
$ -27.72M
|
$ -27.38M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -119.44M
|
$ 4.73M
|
$ 6.94M
|
|
PE Ratio
|
|
|
|
|
|
|